| Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis JD Rohrer, JM Nicholas, DM Cash, J Van Swieten, E Dopper, L Jiskoot, ... The Lancet Neurology 14 (3), 253-262, 2015 | 584 | 2015 |
| Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study KM Moore, J Nicholas, M Grossman, CT McMillan, DJ Irwin, L Massimo, ... The Lancet Neurology 19 (2), 145-156, 2020 | 281 | 2020 |
| MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases L Harper, GG Fumagalli, F Barkhof, P Scheltens, JT O’Brien, F Bouwman, ... Brain 139 (4), 1211-1225, 2016 | 265 | 2016 |
| Circulating miRNAs as potential biomarkers in Alzheimer's disease D Galimberti, C Villa, C Fenoglio, M Serpente, L Ghezzi, SMG Cioffi, ... Journal of Alzheimer's Disease 42 (4), 1261-1267, 2014 | 236 | 2014 |
| Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study DM Cash, M Bocchetta, DL Thomas, KM Dick, JC van Swieten, B Borroni, ... Neurobiology of aging 62, 191-196, 2018 | 191 | 2018 |
| Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study EL van der Ende, LH Meeter, JM Poos, JL Panman, LC Jiskoot, ... The Lancet Neurology 18 (12), 1103-1111, 2019 | 170 | 2019 |
| Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study C Pottier, X Zhou, RB Perkerson, M Baker, GD Jenkins, DJ Serie, ... The Lancet Neurology 17 (6), 548-558, 2018 | 127 | 2018 |
| Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation D Galimberti, C Fenoglio, M Serpente, C Villa, R Bonsi, A Arighi, ... Biological psychiatry 74 (5), 384-391, 2013 | 126 | 2013 |
| MiRNA profiling in plasma neural-derived small extracellular vesicles from patients with Alzheimer’s disease M Serpente, C Fenoglio, M D’Anca, M Arcaro, F Sorrentino, C Visconte, ... Cells 9 (6), 1443, 2020 | 82 | 2020 |
| Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations A Arighi, GG Fumagalli, F Jacini, C Fenoglio, L Ghezzi, AM Pietroboni, ... Journal of Alzheimer's Disease 31 (2), 447-452, 2012 | 81 | 2012 |
| Role of hnRNP-A1 and miR-590-3p in Neuronal Death: Genetics and Expression Analysis in Patients with Alzheimer Disease and Frontotemporal Lobar … C Villa, C Fenoglio, M De Riz, F Clerici, A Marcone, L Benussi, R Ghidoni, ... Rejuvenation research 14 (3), 275-281, 2011 | 76 | 2011 |
| White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort CH Sudre, M Bocchetta, D Cash, DL Thomas, I Woollacott, KM Dick, ... NeuroImage: Clinical 15, 171-180, 2017 | 75 | 2017 |
| Inflammatory molecules in frontotemporal dementia: cerebrospinal fluid signature of progranulin mutation carriers D Galimberti, R Bonsi, C Fenoglio, M Serpente, SMG Cioffi, G Fumagalli, ... Brain, behavior, and immunity 49, 182-187, 2015 | 72 | 2015 |
| Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred AM Pietroboni, GG Fumagalli, L Ghezzi, C Fenoglio, F Cortini, M Serpente, ... Journal of Alzheimer's Disease 24 (2), 253-259, 2011 | 71 | 2011 |
| Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study HJMM Mutsaerts, SS Mirza, J Petr, DL Thomas, DM Cash, M Bocchetta, ... Brain 142 (4), 1108-1120, 2019 | 66 | 2019 |
| Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study D Galimberti, GG Fumagalli, C Fenoglio, SMG Cioffi, A Arighi, M Serpente, ... Neurobiology of aging 62, 245. e9-245. e12, 2018 | 61 | 2018 |
| Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters A Arighi, GG Fumagalli, T Carandini, AM Pietroboni, MA De Riz, ... Neurological Sciences 42, 1247-1251, 2021 | 58 | 2021 |
| Progression of behavioral disturbances and neuropsychiatric symptoms in patients with genetic frontotemporal dementia A Benussi, E Premi, S Gazzina, C Brattini, E Bonomi, A Alberici, L Jiskoot, ... JAMA Network open 4 (1), e2030194-e2030194, 2021 | 57 | 2021 |
| Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia T Rittman, R Borchert, S Jones, J van Swieten, B Borroni, D Galimberti, ... Neurobiology of Aging 77, 169-177, 2019 | 56 | 2019 |
| The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients AM Pietroboni, L Dell’Arti, M Caprioli, M Scarioni, T Carandini, A Arighi, ... Multiple Sclerosis Journal 25 (1), 31-38, 2019 | 55 | 2019 |
